How the Golgi's COG complex helps move and modify proteins inside cells

Characterization of mammalian COG complex-interacting Golgi trafficking machinery

NIH-funded research Univ of Arkansas for Med Scis · NIH-11310153

The team will look at how a protein complex called COG controls protein traffic in human cells to better understand conditions like congenital glycosylation disorders, Alzheimer’s changes, and some cancers.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Arkansas for Med Scis NIH-funded
Lab location1 site (Little Rock, United States)
Project IDNIH-11310153 on NIH RePORTER

What this research studies

From a patient's point of view, researchers will map how the COG complex physically connects with other proteins that guide cargo through the cell's Golgi "shipping center." They will use lab-based methods such as pairwise interaction tests, timing (kinetic) measurements, and proximity-labeling to see which partners are nearby. The team will also study what happens when COG is reduced and specific transport vesicles build up. These experiments are done in cells and biochemical systems to reveal molecular steps that could go wrong in disease.

Who could benefit from this research

Good fit: People with congenital disorders of glycosylation, certain forms of dementia, or cancers might be the kinds of patients who could benefit from or be included in follow-up studies based on these findings.

Not a fit: Patients seeking immediate treatments should not expect direct benefit from this basic laboratory research, since it focuses on cellular mechanisms rather than clinical interventions.

Why it matters

Potential benefit: If successful, this work could reveal new molecular targets or biomarkers that lead to future diagnostics or therapies for certain genetic glycosylation disorders, neurodegeneration, or cancers.

How similar studies have performed: Related molecular-mapping methods have uncovered disease mechanisms before, but detailed pairwise mapping of COG interactions and their kinetic environment is relatively new.

Where this research is happening

Little Rock, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseCancers
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.